1Schotthoefer AM, Frost HM. Ecology and Epidemiology of Lyme Borreliosis. Clin Lab Med. 2015;35:723-43.
2Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015;57:82-115.
3Sanchez JL. Clinical Manifestations and Treatment of Lyme Disease. Clin Lab Med. 2015;35:765-78.
4Tilly K, Rosa PA, Stewart PE. Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am. 2008;22:217-34, v.
5Polat E, Turhan V, Aslan M, Musellim B, Onem Y, Ertugrul B. [First report of three culture confirmed human Lyme cases in Turkey]. Mikrobiyol Bul. 2010;44:133-9.
6Guner ES, Hashimoto N, Takada N, Kaneda K, Imai Y, Masuzawa T. First isolation and characterization of Borrelia burgdorferi sensu lato strains from Ixodes ricinus ticks in Turkey. J Med Microbiol. 2003;52:807-13.
7Pritt BS, Mead PS, Johnson DK, Neitzel DF, Respicio-Kingry LB, Davis JP, Schiffman E, Sloan LM, Schriefer ME, Replogle AJ, Paskewitz SM, Ray JA, Bjork J, Steward CR, Deedon A, Lee X, Kingry LC, Miller TK, Feist MA, Theel ES, Patel R, Irish CL, Petersen JM. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016;16:556-64.
8Herrmann C, Gern L. Search for blood or water is influenced by Borrelia burgdorferi in Ixodes ricinus. Parasit Vectors. 2015;8:6.
9CDC. Lyme disease data tables 2016 [21.04.2016]. Available from: http:// www.cdc.gov/lyme/stats/tables.html.
10Ozdemir D, İnce N. Lyme Disease. J Microbiol Infect Dis. 2014;(Suppl 1):S32-S40.
11Yemişen M, Mete B, Balkan İİ. Lyme hastalığı. J Exp Clin Med. 2012:169-74.
12Anlar FY, Durlu Y, Aktan G, Acikgoz E, Bingol N, Madencioglu V, Anlar B. [Clinical characteristics of Lyme disease in 12 cases]. Mikrobiyol Bul. 2003;37:255-9.
13Guner ES, Hashimoto N, Kadosaka T, Imai Y, Masuzawa T. A novel, fastgrowing Borrelia spp. isolated from the hard tick Hyalomma aegyptium in Turkey. Microbiology. 2003;149:2539-44.
14Kaygusuz I, Godekmerdan A, Karlidag T, Keles E, Yalcin S, Tazegul A. [An investigation of patients with acute peripheral facial palsy with regard to Lyme disease]. Kulak Burun Bogaz Ihtis Derg. 2003;10:143-7.
15Guner ES, Watanabe M, Kadosaka T, Polat E, Gargili A, Gulanber A, Ohashi N, Kaneda K, Imai Y, Masuzawa T. Seroepidemiology of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in wild mice captured in northern Turkey. Epidemiol Infect. 2005;133:331-6.
16Gunes T, Poyraz O, Kaya S, Gencer L, Alim A. [Investigation of vectors for Borrelia burgdorferi and Lyme seropositivity in Sivas region]. Mikrobiyol Bul. 2005;39:503-8.
17Bhide M, Yilmaz Z, Golcu E, Torun S, Mikula I. Seroprevalence of anti- Borrelia burgdorferi antibodies in dogs and horses in Turkey. Ann Agric Environ Med. 2008;15:85-90.
18Kaya AD, Parlak AH, Ozturk CE, Behcet M. Seroprevalence of Borrelia burgdorferi infection among forestry workers and farmers in Duzce, northwestern Turkey. New Microbiol. 2008;31:203-9.
19Sen E, Uchishima Y, Okamoto Y, Fukui T, Kadosaka T, Ohashi N, Masuzawa T. Molecular detection of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes ricinus ticks from Istanbul metropolitan area and rural Trakya (Thrace) region of north-western Turkey. Ticks Tick Borne Dis. 2011;2:94-8.
20Aslan Basbulut E, Gozalan A, Sonmez C, Coplu N, Korhasan B, Esen B, Akin L, Ertek M. [Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey]. Mikrobiyol Bul. 2012;46:247-56.
21Parlak M, Bayram Y, Cikman A, Ceylan N, Berktas M. [Seropositivity of Borrelia burgdorferi in risky groups in Van region, Turkey]. Mikrobiyol Bul. 2015;49:439-45.
22Birengel S, Boşca A, Kurt H. Tekeli E. Sağlıklı bireylerde ve bazı hasta gruplarında lyme seropozitifliği. FLORA. 1999;4:51-7.
23Çelik A, Turgut H, Çetin Ç, Yalçın A. Kaleli İ. Denizli yöresinde Borrelia burgdorferi antikor sıklığının araştırılması. İnfeksiyon Dergisi. 2001;15:439-41
24Aydın K, Köksal İ, Çaylan R, Karagüzel A, Volkan S, Kaygusuz S, Öksüz R, Kostakoğlu U. Trabzon yöresinde lyme seropozitifliği. İnfek Derg 2001;15:141-4.
25Demirci M, Yorgancıgil B, Tahan V, Arda M. Lyme disease seropositivity in people with history of tick bite in the Isparta region of Turkey. İnfek Derg. 2001;15.
26Göral G, Kılıçturgay K, Aydın L. Antibody prevalence against Borrelia burgdorferi in some villages in the province of Bilecik. Turk J Med Sci. 1997;1997:51-3.
27Hızel K, Ulutan F, Akta F. Lyme hastalığı ile uyumlu bulgusu olan hastalarda Borrelia burgdorferi antikorlarının araştırılması. İnfek Derg. 1997;11:87-91.
28Mutlu G, Gültekin M, Ergin Ç, Sayın F, Kurşun AE. Antalya yöresinde Borrelia burgdorferi antikorlarının ve vektörlerinin araştırılması. Mikrobiyol Bult. 1995;29:1-6.
29Utaş S, Kardaş Y, Doğanay M. Borrelia burgdorferi ile ilişkili olabilecek semptomları olan hasta grubunun Lyme serolojisi yönünden değerlendirilmesi. Mikrobiyol Bult. 1994;28:106-12.
30Bucak O, Kocoglu ME, Tas T, Mengeloglu FZ. Evaluation of Borrelia burgdorferi sensu lato seroprevalence in the province of Bolu, Turkey. Turk J Med Sci. 2016;46:727-32.
31Klinik Bakteriyoloji Tanı Standartları Çalışma Grubu (Türkiye Halk Sağlığı Kurumu). Lyme Hastalığının (Borrelia burgdorferi enfeksiyonunun) Mikrobiyolojik Tanısı [Internet]. 2015. Available from: http://mikrobiyoloji. thsk.saglik.gov.tr/Dosya/tani-rehberi/bakteriyoloji/UMS-B-MT-24-Lymehastaligi. pdf.
32Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004;113:1093-101.
33Rosa P. Lyme disease agent borrows a practical coat. Nat Med. 2005;11:831-2
34Baranton G, De Martino SJ. Borrelia burgdorferi sensu lato diversity and its influence on pathogenicity in humans. Curr Probl Dermatol. 2009;37:1-17.
35Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461-73
36Feder HM, Jr., Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. Clin Dermatol. 2006;24:509-20.
37Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-134.
38Meyerhoff JO, Zaidman GW, Steele RW. Lyme Disease: Medscape; 2015 [updated 21.01.2015; cited 2016 21.01.2016]. Available from: http:// emedicine.medscape.com/article/330178-overview.
39Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA. 2007;297:2617-27.
40Nigrovic LE, Thompson AD, Fine AM, Kimia A. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme disease-endemic area. Pediatrics. 2008;122:e1080-5.
41Aiyer A, Hennrikus W, Walrath J, Groh B, Ostrov B. Lyme arthritis of the pediatric lower extremity in the setting of polyarticular disease. J Child Orthop. 2014;8:359-65.
42Varela AS, Luttrell MP, Howerth EW, Moore VA, Davidson WR, Stallknecht DE, Little SE. First culture isolation of Borrelia ionestari, putative agent of southern tick-associated rash illness. J Clin Microbiol. 2004;42:1163-9.
43Bransfield RC, Wulfman JS, Harvey WT, Usman AI. The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders. Med Hypotheses. 2008;70:967-74.
44Burbelo PD, Swedo SE, Thurm A, Bayat A, Levin AE, Marques A, Iadarola MJ. Lack of serum antibodies against Borrelia burgdorferi in children with autism. Clin Vaccine Immunol. 2013;20:1092-3.
45Ajamian M, Kosofsky BE, Wormser GP, Rajadhyaksha AM, Alaedini A. Serologic markers of Lyme disease in children with autism. JAMA. 2013;309:1771-3.
46Bransfield RC. The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms. Open Neurol J. 2012;6:88-93.
47Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R. Lyme borreliosis in Europe. Euro Surveill. 2011;16.
48CDC. Lyme Disease 2016. Available from: http://www.cdc.gov/lyme/ diagnosistesting/labtest/twostep/index.html.
49European Union Concerted Action on Lyme Borreliosis 2016. Available from: http://www.eucalb.com/.
50Linden H. Treatment of Lyme disease: Uptodate; 2016. Available from: http:// www.uptodate.com/contents/treatment-of-lyme-disease?source=search_ result&search=lyme+disease+treatment&selectedTitle=1~150.